Intermediates + Impurities
- Cetirizine Hydrochloride
- Doxazosin Mesylate
- Pazufloxacin Mesylate
- Omadacycline Tosylate
- Perampanel 3/4 hydrate
- Brexpiprazole
- Selexipag
- Lumateperone Tosylate
- Gadoxetate Disodium
- Suzetrigine VX-548
- Fezolinetant
- Daridorexant Hydrochloride
- Lemborexant
- Brinzolamide
- Lifitegrast
- Diquafosol Tetrasodium
- Lefamulin Acetate
- Netupitant
- Brivaracetam
- Bedaquiline Fumurate
- Lomefloxacin Hydrochloride
- Palonosetron Hydrochloride
- Suvorexant
- Tedizolid Phosphate
- Vonoprazan Fumurate
- Valbenazine Tosylate
- Ozanimod Hydrochloride
- Netasudil Dimesylate
Netupitant
-
Netupitant
【Chemical Name】Netupitant
【Original】Roche
【Time to market】2014.10.10
【Dosage and Usage】Capsules: 300 mg netupitant/0.5 mg palonosetron;
For Injection: 235 mg fosnetupitant/0.25 mg palonosetron as a lyophilized powder in single-dose vial for reconstitution
Injection: 235 mg fosnetupitant/0.25 mg palonosetron solution in single dose 20 mL vial
Used for the treatment of the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.